Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-123 |
Sentence |
denotes |
Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells. |
T1 |
0-123 |
Sentence |
denotes |
Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells. |
TextSentencer_T2 |
124-354 |
Sentence |
denotes |
The neoglycoproteins that consist of human serum albumin (HSA) modified with mannose 6-phosphate ([M6P]x-HSA) were synthesized, and they showed high binding property to hepatic stellate cells (HSC) by immunohistochemical analysis. |
T2 |
124-354 |
Sentence |
denotes |
The neoglycoproteins that consist of human serum albumin (HSA) modified with mannose 6-phosphate ([M6P]x-HSA) were synthesized, and they showed high binding property to hepatic stellate cells (HSC) by immunohistochemical analysis. |
TextSentencer_T3 |
355-481 |
Sentence |
denotes |
In addition, an increased substitution (X) of 6-phosphated mannose (M6P) was associated with an increased accumulation in HSC. |
T3 |
355-481 |
Sentence |
denotes |
In addition, an increased substitution (X) of 6-phosphated mannose (M6P) was associated with an increased accumulation in HSC. |
TextSentencer_T4 |
482-543 |
Sentence |
denotes |
So the [M6P]x-HSA might be a carrier to deliver drugs to HSC. |
T4 |
482-543 |
Sentence |
denotes |
So the [M6P]x-HSA might be a carrier to deliver drugs to HSC. |
TextSentencer_T5 |
544-620 |
Sentence |
denotes |
The antifibrotic drug, glycyrrhetin, was chosen to conjugate to M6P(26)-HSA. |
T5 |
544-620 |
Sentence |
denotes |
The antifibrotic drug, glycyrrhetin, was chosen to conjugate to M6P(26)-HSA. |
TextSentencer_T6 |
621-731 |
Sentence |
denotes |
The result suggests there were 6 approximately 7 glycyrrhetin molecules having been conjugated to the carrier. |
T6 |
621-731 |
Sentence |
denotes |
The result suggests there were 6 approximately 7 glycyrrhetin molecules having been conjugated to the carrier. |
TextSentencer_T7 |
732-821 |
Sentence |
denotes |
Targeting glycyrrhetin to HSC might reduce its adverse affects and increase the efficacy. |
T7 |
732-821 |
Sentence |
denotes |
Targeting glycyrrhetin to HSC might reduce its adverse affects and increase the efficacy. |